Yazar "Uğurlu H." için listeleme
-
Open, prospective, multi-center, two-part study of patient preference with monthly ibandronate therapy in women with postmenopausal osteoporosis switched from daily or weekly alendronate or risendronate-BONCURE: Results of Turkish sub-study
Eskiyurt N.; Irdesel J.; Sepici V.; Uğurlu H.; Kirazli Y.; Ardiç F.; Öncel H. (Galenos Yayincilik,, 2012)Aim: BONCURE (Bonviva for Current Bisphosphonate Users Regional European Trial), aimed to evaluate patient preference with monthly ibandronate in women with postmenopausal osteoporosis who previously received daily or ...